Log in to save to my catalogue

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and...

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1686067304

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression

About this item

Full title

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression

Publisher

Dordrecht: Springer Netherlands

Journal title

Pathology oncology research, 2015-07, Vol.21 (3), p.589-595

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Summary
HER-2/neu extracellular domain (ECD) can be detected in blood as a soluble circulating protein. The aim of this study was to analyze the relationship between HER-2/neu extracellular domain in the serum and the prognosis in breast cancer patients. We also correlated HER-2/neu ECD with various clinicopathological factors including steroid...

Alternative Titles

Full title

Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1686067304

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1686067304

Other Identifiers

ISSN

1219-4956

E-ISSN

1532-2807

DOI

10.1007/s12253-014-9859-6

How to access this item